AAMU
PCRX icon

Amundi Asset Management US’s Pacira BioSciences PCRX Stock Holding History

Amundi Asset Management US’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$189K Hold
2,700
– – ﹤0.01% 1467
2020
Q4 		$162K Hold
2,700
– – ﹤0.01% 1417
2020
Q3 		$162K Hold
2,700
– – ﹤0.01% 1402
2020
Q2 		$142K Hold
2,700
– – ﹤0.01% 1415
2020
Q1 		$91K Buy
2,700
+600
+29% +$24.9K ﹤0.01% 1444
2019
Q4 		$95K Hold
2,100
– – ﹤0.01% 1559
2019
Q3 		$80K Buy
2,100
+400
+24% +$16K ﹤0.01% 1561
2019
Q2 		$74K Hold
1,700
– – ﹤0.01% 1590
2019
Q1 		$65K Buy
+1,700
New +$66.3K ﹤0.01% 1569

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return